Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOXSIALO-TRIAL: Botox versus scopolamine for drooling in children with cerebral palsy
2021-000095-10Phase 4Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A and scopolamine in hypersalivation (2 arms), sponsored by Hospices Civils de Lyon. Started Jun 2021; status: active.
02
Drugs
botulinum toxin type Ascopolamine
03
Conditions
hypersalivation
Beyond the preview
Go deeper on 2021-000095-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000095-10.